Identification of a novel GSK3 beta specific small molecule inhibitor involved in regulating Wnt beta catenin signaling in KRAS mutant pancreatic cancers

Abstract

newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced